China Renaissance
China Renaissance Holdings Limited
China Renaissance is a Beijing-based, Hong Kong-listed investment bank and investment manager focused on China's technology and new-economy companies. Its US broker-dealer, China Renaissance Securities (US) Inc., publishes research on US-listed stocks.
Company history
Bao Fan, a former Morgan Stanley and Credit Suisse banker, founded China Renaissance in 2005 as an advisor to Chinese startups. It obtained securities licences in Hong Kong in 2012, the United States in 2013 and mainland China in 2016, advised on the 2015 Didi–Kuaidi and Meituan–Dianping mergers, and listed in Hong Kong in 2018. Bao was detained by Chinese authorities in 2023 and resigned in 2024; Wang Lixing became chief executive in November 2024.
- 2005Bao Fan founds China Renaissance
- 2013Begins licensed securities business in the United States
- 2015Advises on Didi–Kuaidi and Meituan–Dianping mergers
- 2018Lists on the Hong Kong Stock Exchange main board
- 2023Founder Bao Fan detained; share trading suspended
- 2024Trading resumes; Wang Lixing named chief executive
Research
Research covers Chinese internet, consumer and technology companies listed in Hong Kong and the United States, and the US unit also rates non-Chinese US-listed stocks. Buy, Hold and Sell ratings measure expected performance against the benchmark index of the stock's primary exchange, such as the S&P 500 for US listings, over 12 to 18 months.
Coverage12M
- Stocks
- 15
- Ratings
- 5
- Price targets
- 11
- Median upside
- +20.5%
- Upgrades
- 1
- Downgrades
- 4
- Initiations
- 0
- Reiterations
- 0
- Positive20%1
- Neutral80%4
- Negative0%0
Sectors
Ratings
Listing
Activity24M
Most covered24M
| Stock | Rating | Target |
|---|---|---|
 GRABGrab Holdings Limited | Buy | $7 |
 AAPLApple Inc. | Hold | — |
 BBWIBath & Body Works, Inc. | — | $20 |
 BROSDutch Bros Inc. | — | $73 |
 CRNXCrinetics Pharmaceuticals, Inc. | — | $105 |
 EYPTEyePoint Pharmaceuticals, Inc. | — | $4 |
 GHGuardant Health, Inc. | — | $70 |
 KNTKKinetik Holdings Inc. | — | $57 |
 LILi Auto Inc. | Hold | — |
 MUMicron Technology, Inc. | Hold | — |
Analysts24M
- Tempus AIGH1
Recent actions
| Stock | Rating action | Rating | Target | Date |
|---|---|---|---|---|
| Bath & Body Works, Inc.BBWI | Target | $20 | Sep 8 | |
 Snowflake Inc.SNOW | Target | $297 | Sep 3 | |
| EyePoint Pharmaceuticals, Inc.EYPT | Target | $4 | Sep 2 | |
| Kinetik Holdings Inc.KNTK | Target | $57 | Aug 17 | |
 Tronox Holdings plcTROX | Target | $5 | Aug 13 | |
 Tencent Music Entertainment GroupTME | Downgrade | Buy →Hold | Aug 12 | |
| Grab Holdings LimitedGRAB | Target | $7 | Aug 4 | |
| Apple Inc.AAPL | Downgrade | Buy →Hold | Aug 4 | |
| TCTrip.com Group LimitedTCOM | Downgrade | Buy →Hold | Jul 2 | |
| WRWarby Parker Inc.WRBY | Target | $30 | May 22 | |
| Dutch Bros Inc.BROS | Target | $73 | May 20 | |
| Grab Holdings LimitedGRAB | Upgrade | Hold →Buy | May 6 |
Similar coverage12M
References
- About Us - China Renaissancechinarenaissance.com
- China Renaissance Holdings director information (May 2026) - HKEXnewshkexnews.hk
- China Renaissance announcement on resumption of trading (September 2024) - HKEXnewswww1.hkexnews.hk
- China Renaissance makes debut on HKEX - CNBCcnbc.com
- China Renaissance research report with rating definitions (December 2020)research.chinarenaissance.com
- China Renaissance Analyst Recommendations - MarketBeatmarketbeat.com